[13C] methionine breath test as a marker for hepatic mitochondrial function in HIV-infected patients

AIDS Research and Human Retroviruses

Volumn 25, Issue 12, 2009, Pages 1243-1248

  Sternfeld, T ^a   Lorenz, A ^b   Schmid, M ^c   Schlamp, A ^c   Demmelmair, H ^c   Koletzko, B ^c   Bogner, J R ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Deggendorf   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; METHIONINE C 13; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; METHIONINE;

ADULT; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRIGLYCERIDEMIA; LIPOHYPERTROPHY; LIVER MITOCHONDRION; MALE; METHIONINE C 13 BREATH TEST; PRIORITY JOURNAL; SENESCENCE; AGE; LIPID METABOLISM; LIVER DISEASE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PHYSIOLOGY; REPRODUCIBILITY; VIROLOGY;

ADULT; AGE FACTORS; BREATH TESTS; FEMALE; HIV INFECTIONS; HUMANS; LIPID METABOLISM; LIVER DISEASES; MALE; METHIONINE; MIDDLE AGED; MITOCHONDRIA, LIVER; MULTIVARIATE ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 73149120059     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0013     Document Type: Article

References (29)

1. Bonnet F, Chene G, Thiebaut R, et al.: Trends and determinants of severe morbidity in HIV-infected patients: The ANRS CO3 Aquitaine Cohort, 2000-2004. HIV Med 2007;8:547-554.
2. Bauer AM, Sternfeld T, Horster S, et al.: Kinetics of lactate metabolism after submaximal ergometric exercise in HIVinfected patients. HIV Med 2004;5:371-376.
3. Kohler JJ and Lewis W: A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen 2007;48:166-172.
4. Kakuda TN: Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000;22:685-708.
5. Koletzko B, Demmelmair H, Hartl W, et al.: The use of stable isotope techniques for nutritional and metabolic research in paediatrics. Early Hum Dev 1998;53(Suppl):S77-S97.
6. Banasch M, Goetze O, Hollborn I, et al.: 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr 2005;40:149-154.
7. Milazzo L, Piazza M, Sangaletti O, et al.: [13C]Methionine breath test: A novel method to detect antiretroviral drugrelated mitochondrial toxicity. J Antimicrob Chemother 2005;55:84-89.
8. Milazzo L, Riva A, Sangaletti O, et al.: 13C-Methionine breath test detects liver mitochondrial impairment in HIV-infected patients with antiretroviral drug-related hyperlactatemia. J Acquir Immune Defic Syndr 2004;35:429-432.
9. Armuzzi A, Marcoccia S, Zocco MA, et al.: Non-Invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test. Scand J Gastroenterol 2000; 35:650-653.
10. Ishii Y, Asai S, Kohno T, et al.: Evaluation of liver regeneration using the L-[1-13C]methionine breath test. J Surg Res 2001;95:195-199.
11. Spahr L, Negro F, Leandro G, et al.: Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. Med Sci Monit 2003;9:CR6-CR11.
12. Casademont J, Sanjurjo E, Garrabou G, and Miro O: Diagnosis of mitochondrial dysfunction in HIV-infected patients under highly active antiretroviral therapy: Possibilities beyond the standard procedures. Antivir Ther 2005;10(Suppl 2):M65-M71.
13. Spahr L, Negro F, Rubbia-Brandt L, et al.: Acute valproateassociated microvesicular steatosis: Could the [13C]methionine breath test be useful to assess liver mitochondrial function? Dig Dis Sci 2001;46:2758-2761.
14. Candelli M, Armuzzi A, Nista EC, et al.: 13C-Methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 2004;19:243.
15. Candelli M, Cazzato IA, Zocco MA, et al.: 13C-breath tests in the study of mitochondrial liver function. Eur Rev Med Pharmacol Sci 2004;8:23-31. (Pubitemid 38659919)
16. Miele L, Grieco A, Armuzzi A, et al.: Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. Am J Gastroenterol 2003;98:2335-2336.
17. Di Campli C, Angelini G, Armuzzi A, et al.: Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation. Eur J Gastroenterol Hepatol 2003;15:727-732.
18. Armuzzi A, Candelli M, Zocco MA, et al.: Review article: Breath testing for human liver function assessment. Aliment Pharmacol Ther 2002;16:1977-1996.
19. Kinsell LW, Harper HA, Barton HC, Michaels GD, and Weiss HA: Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science 1947;106:589-590.
20. Horowitz JH, Rypins EB, Henderson JM, et al.: Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology 1981;81:668-675.
21. Alberici LC, Oliveira HC, Bighetti EJ, et al.: Hypertriglyceridemia increases mitochondrial resting respiration and susceptibility to permeability transition. J Bioenerg Biomembr 2003;35:451-457.
22. Pessayre D, Berson A, Fromenty B, and Mansouri A: Mitochondria in steatohepatitis. Semin Liver Dis 2001;21:57-69.
23. Lichtenstein KA: Redefining lipodystrophy syndrome: Risks and impact on clinical decision making. J Acquir Immune Defic Syndr 2005;39:395-400.
24. Milazzo L, Menzaghi B, Massetto B, Sangaletti O, and Riva A: 13C-methionine breath test detects drug-related hepatic mitochondrial dysfunction in HIV-infected patients. J Acquir Immune Defic Syndr 2006;41:252-253.
25. Milazzo L, Menzaghi B, Massetto B, Sangaletti O, and Riva A: 13C-methionine breath test detects drug-related hepatic mitochondrial dysfunction in HIV-infected patients. J Acquir Immune Defic Syndr 2006;41: author reply 253-254.
26. Loeb LA, Wallace DC, and Martin GM: The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc Natl Acad Sci USA 2005;102:18769-18770.
27. Carr A: HIV lipodystrophy: Risk factors, pathogenesis, diagnosis and management. AIDS 2003;17(Suppl 1):S141-S148.
28. Kang D and Hamasaki N: Alterations of mitochondrial DNA in common diseases and disease states: Aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem 2005;12:429-441.
29. Velsor LW, Kovacevic M, Goldstein M, et al.: Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine. Toxicol Appl Pharmacol 2004;199:10-19.